Each forms can result in too much daytime sleepiness. Scientific studies suggest that modafinil could be a promising drug that will reduce equally daytime sleepiness and myotonia by itself, with no substantial cardiac conduction outcomes, and that is very important for clients with myotonic dystrophy who typically have fundamental cardiac issues.[2